BCM
AGEN

Bayesian Capital Management’s Agenus AGEN Stock Holding History

Bayesian Capital Management’s Portfolio AGEN Stock Details AGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,525
Closed -$176K – 650
2024
Q2 		$176K Buy
+10,525
New +$127K 0.02% 616
2024
Q1 		– Sell
-515
Closed -$8.53K – 757
2023
Q4 		$8.53K Buy
+515
New +$8.53K ﹤0.01% 702
2023
Q2 		– Sell
-1,890
Closed -$56.4K – 763
2023
Q1 		$56.4K Sell
1,890
-3,796
-67% -$160K 0.01% 712
2022
Q4 		$268K Buy
5,686
+5,100
+870% +$259K 0.04% 517
2022
Q3 		$24K Sell
586
-219
-27% -$11.2K ﹤0.01% 638
2022
Q2 		$31K Buy
+805
New +$29.2K 0.01% 726

Other funds holding AGEN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bayesian Capital Management's AGEN Position: Q3 2024 in Review

Bayesian Capital Management sold out of Agenus (AGEN) in Q3 2024, closing a stake of 10,525 shares — an estimated $176K sold.

Bayesian Capital Management first reported a position in AGEN in Q2 2022 and held it in 6 quarters. The position peaked at $268K in Q4 2022. 98 funds tracked by Wall St. Rank hold AGEN as of Q3 2024.

  • Bayesian Capital Management reported no remaining Agenus position as of Q3 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 10,525 Agenus shares in Q3 2024, an estimated $176K.
  • Bayesian Capital Management first reported a position in Agenus in Q2 2022 and held it in 6 quarters.
  • Bayesian Capital Management's Agenus position peaked at $268K in Q4 2022.
  • 98 funds tracked by Wall St. Rank held Agenus as of Q3 2024.

Based on Bayesian Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.